A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus
Authors:
- Gerlinde R. Van de WalleGWGerlinde R. Van de Walle
- Maeva A. MayMMMaeva A. May
- Nikolaus OsterriederNONikolaus Osterrieder
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Untersuchungen zur Entwicklung eines Lebendimpfstoffes gegen die Rhinopneumonitis (Stutenabort) der Pferde1Zentralblatt für Veterinärmedizin Reihe B, 2010
- A Single‐Nucleotide Polymorphism in a Herpesvirus DNA Polymerase Is Sufficient to Cause Lethal Neurological DiseaseThe Journal of Infectious Diseases, 2009
- Protection of Mice by Equine Herpesvirus Type 1–Based Experimental Vaccine against Lethal Venezuelan Equine Encephalitis Virus Infection in the Absence of Neutralizing AntibodiesThe American Journal of Tropical Medicine and Hygiene, 2008
- Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV)Virus Research, 2007
- Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteinsJournal of General Virology, 2007
- Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)Vaccine, 2006
- Equine herpesvirus type 1 modified live virus vaccines:quo vaditis?Expert Review of Vaccines, 2006
- Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) – epidemiology, disease and immunoprophylaxis: A brief reviewThe Veterinary Journal, 2005
- The Equine Herpesvirus 1 IR6 Protein Influences Virus Growth at Elevated Temperature and Is a Major Determinant of VirulenceVirology, 1996
- The Equine Herpesvirus 1 IR6 Protein Is Nonessential for Virus Growthin Vitroand Modified by Serial Virus Passage in Cell CultureVirology, 1996